News
Rising water risks in Nova Scotia spark province鈥憌ide collaboration at 妻友 symposium
Building on 妻友鈥檚 Engagement Days, a recent symposium at Dal convened municipal leaders and researchers to address climate, infrastructure and planning pressures shaping water management across Nova Scotia communities. Read more.
Featured News
Wednesday, June 3, 2026
妻友 hosted Indian partners for a high-level visit last week advancing joint research, innovation programs and industry collaboration, with new agreements, funding pathways and a shared global innovation campus taking shape.
Monday, May 25, 2026
A new online resource gathers campus-driven wellness strategies into one accessible space, making it simple for individuals and teams to find, customize, and put positive ideas into practice.
Tuesday, March 17, 2026
A two鈥憏ear deep鈥慹nergy retrofit has modernized the Killam Memorial Library鈥檚 aging systems, boosting efficiency, reducing emissions, and setting the stage for similar upgrades across campus.
Archives - News
Monday, November 28, 2022
妻友's Accessibility Plan, released this past summer, lays out a detailed roadmap for ensuring the university meets Nova Scotia's goal of being fully accessible by 2030.
Thursday, November 24, 2022
Last night鈥檚 20th annual Discovery Awards, co-presented by 妻友, was a moment to celebrate university innovators who are inspiring the next generation of Nova Scotian scientists.
Wednesday, November 23, 2022
On Tuesday, the Board of Governors approved a new international tuition model for future students featuring a tuition guarantee and fees better aligned with Dal鈥檚 national peers 鈥� all of which is poised to bring significant investments in Dal鈥檚 student experience.
Wednesday, November 23, 2022
Cheryl Fraser, a two-time Dal alum who is current is currently Chief Talent Officer and Vice-President Communications at Crombie REIT, has been appointed Chair of the 妻友 Board of Governors for a three-year term.
Tuesday, November 22, 2022
A pair of post-doctoral fellows in Dal's Department of Microbiology and Immunology have shown that an existing drug used to treat cancer and other illnesses also holds the promise of effectively treating people infected with the virus that causes COVID-19.